BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 10, 2009
View Archived Issues
Multiple phase I studies of Exelixis oncolytic products reported
Read More
Promising phase I and II data on foretinib in solid tumor therapy
Read More
Novel ZAP-70 inhibitors in early development at Cellzone
Read More
Novel platinum compounds disclosed by sanofi-aventis for cancer therapy
Read More
Bayer Schering Pharma claims novel HIF prolyl hydroxylase inhibitors
Read More
Abbott presents GSK-3beta inhibitors for the treatment of Alzheimer's disease
Read More
Pazopanib increases visual acuity in phase II macular degeneration study
Read More
Apixaban nears regulatory submission in Europe
Read More
FDA approves new formulation of omeprazole
Read More
CPX-351 safety appears acceptable in older patients with acute myeloid leukemia
Read More
Pfizer's p38 MAPK inhibitor PHA-666859 shows potential to treat diabetic retinopathy
Read More
biOasis Technologies and Fleet Bioprocessing develop Alzheimer's disease test
Read More
Rufinamide efficacious in adults and children with epilepsy
Read More
FDA approves SonoCine automated whole-breast ultrasound method
Read More
Pharming completes pre-BLA meeting with FDA for Rhucin in hereditary angioedema
Read More
Novo Nordisk in-licenses IL-21 monoclonal antibody from ZymoGenetics
Read More
Dow Chemical forms independent company Pfenex to develop recombinant proteins
Read More
National Fragile X Foundation awards grant to UC Davis M.I.N.D. Institute
Read More
BHR Pharma files IND with FDA for progesterone in traumatic brain injury
Read More
Hemodynamic Therapeutics completes phase II trial of HTI-101 in hypertension
Read More
FDA approves Octapharma's Wilate for treatment of von Willebrand disease
Read More
FDA approves Tris Pharma's two NDAs for clonidine ER suspension and tablets
Read More
AEterna Zentaris reports results from phase III Z-036 efficacy trial of cetrorelix in BPH
Read More
EnVivo reports results from study of EVP-0962 in Alzheimer's disease
Read More
Vissane approved in Europe for endometriosis
Read More